ABSTRACT This article is aimed at presenting the clinical features and management of two distinct subtypes of Iridocorneal Endothelial Syndrome (ICE), highlighting the importance of differential diagnosis and individualized treatment. It shows two case reports of female patients with progressive visual loss. Ophthalmologic examination was performed, including biomicroscopy, gonioscopy, and specular microscopy. Treatment was defined according to clinical need. The first patient, diagnosed with Cogan-Reese Syndrome, presented with pigmented nodules on the iris, uveal ectropion, and posterior synechiae, being treated […]

ABSTRACT Objective: To evaluate the impact of selective laser trabeculoplasty (SLT) on resource savings and medication costs. Methods: Retrospective study of patients with open-angle glaucoma (OAG) who underwent SLT as a replacement therapy for eye drops and were followed for up to 1 year. The ability to reduce intraocular pressure (IOP) and the amount of eye drops were evaluated, as well as the monthly cost of medications during the follow-up. The annual cost of medications was also calculated. The results […]

ABSTRACT Objective: To evaluate 1-year real-world results of effectiveness and safety of selective laser trabeculoplasty as an alternative to eye drops in patients with early to moderate open-angle glaucoma. Methods: This is a retrospective longitudinal study of a series of cases undergoing selective laser trabeculoplasty in patients with early to moderate open-angle glaucoma who were in use of topical anti-glaucoma therapy. The ability to reduce the intraocular pressure and the medication burden were evaluated, as well as the occurrence of […]

ABSTRACT Objective To evaluate the preliminary medium-term results (up to 6 months) of the stand-alone use of XEN® Gel Stent implantation or in combination with cataract surgery in the Brazilian population. Methods A retrospective longitudinal study was carried out on eyes with primary open-angle glaucoma consecutively submitted to XEN® Gel Stent implantation surgery alone (XEN® Group) or in combination with cataract surgery (Phaco-XEN® Group) in the same center between April and December 2023. The ability to reduce intraocular pressure and […]

ABSTRACT Objective: To evaluate the economic impact of starting the treatment of primary open angle glaucoma with non-pharmacological strategies within the scope of reference centers for the treatment of glaucoma in the Unified Health System. Methods: The population of this study comes from a hypothetical cohort of patients aged 60 years with initial primary open angle glaucoma. The reference strategy (strategy 1) is based only on the use of eye drops, following the guidelines of the clinical protocol of the […]

ABSTRACT Glaucoma is considered the biggest cause of irreversible blindness in the world and the increase in intraocular pressure is its main risk factor. Usually, the initial therapy for glaucoma consists of reducing IOP through the instillation of topical hypotensive drugs, with antiglaucoma surgeries being normally reserved for cases in which disease control is not clinically achieved. Classically, the surgical treatment of glaucoma is performed using filtering procedures: trabeculectomy; non-penetrating sclerotomy and glaucoma drainage devices. The acronym MIGS (Minimally Invasive […]

ABSTRACT Purpose To evaluate the cost-utility of the iStent inject® for the treatment of mild-to-moderate open-angle glaucoma (OAG) within the Brazilian Unified Health System (SUS). Methods A Markov model was developed, in which the effectiveness outcome measure was the incremental cost-effectiveness ratio (ICER: R$ / QALY quality-adjusted life-year). Direct medical costs were obtained from the SUS perspective. The base case comprised of a hypothetical cohort of patients with OAG using topical medication and being managed according to the Clinical Protocol […]

ABSTRACT Minimally invasive glaucoma surgeries are surgical treatment alternatives for glaucoma aimed at reducing intraocular pressure with a better safety profile compared to traditional trabeculectomy. However, in spite of less invasive techniques, complications may develop in any surgical procedure. To the best of our knowledge, this is the first case report of anterior uveitis following combined treatment with cataract surgery and iStent inject® which addresses the management of postoperative inflammation.